Analysis of F-box domain containing effector proteins from Legionella pneumophila
含 F-box 结构域的嗜肺军团菌效应蛋白分析
基本信息
- 批准号:7576736
- 负责人:
- 金额:$ 5.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-02-29 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinity ChromatographyAirAmino Acid MotifsAmoeba genusAnimal Disease ModelsBacteriaBacterial PneumoniaBiological AssayBiological ModelsBreathingCell modelCell physiologyCellsClinicalCommunitiesComplexCytosolDataDevelopmentDisease OutbreaksDrug Delivery SystemsEndoplasmic ReticulumEndosomesEnvironmentEnzymesF Box DomainFamilyFresh WaterGenesGenomeGoalsGram-Negative BacteriaHumanImmuneImmunofluorescence ImmunologicImmunoprecipitationIn VitroIncidenceIndividualInfectionInfection preventionLaboratoriesLegionellaLegionella pneumophilaLegionellosisLegionnaires&apos DiseaseLifeLysosomesMammalian CellMapsMicrobial BiofilmsModificationMolecularNatureParis, FrancePathogenicityPathway interactionsPhagocytesPhagocytosisPharmacologic SubstancePhiladelphiaPlayPneumoniaProcessProliferatingProteinsProteomicsProtozoaRecruitment ActivityRegulatory ElementRoleScreening procedureSite-Directed MutagenesisSterilization for infection controlSwimmingSymptomsSystemType IV Secretion System PathwayUbiquitinationVacuoleVesicleVirulenceWaterWorkaerosolizedantimicrobial drugbactericidecell typeimmune functionlensmacrophagemulticatalytic endopeptidase complexmutantnovelpathogenprotein functionresearch studyresponseubiquitin ligaseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): To breach the human immune defenses, intracellular bacteria can enter, hide and replicate within the host immune cells as well as subvert their immunological functions. This work will characterize the molecular mechanisms that are responsible for this phenomenon, potentially leading to development of novel anti-microbial drug targets. The intracellular human pathogen Legionella pneumophila is the causative agent of the severe bacterial pneumonia known as Legionnaire's disease. Inhalation of aerosolized bacteria results in outbreaks of disease, which can be fatal in people with suppressed immune function. Legionella utilizes an arsenal of proteins injected in the host cell to assume control over various host processes and establish an intracellular replicative niche. The goal of this study is to elucidate the function(s) of a family of Legionella pneumophila proteins that are predicted to alter host cellular responses via subversion of the host ubiquitination regulatory networks. These effector proteins contain the eukaryotic F-box domain, which targets proteins for ubiquitination. Preliminary data showed that these F-box effectors are translocated into the cytosol of host cells during infection and associate with ubiquitinated proteins. Initially the goal of this study is to map the molecular determinant governing the interaction of the F-box effectors with ubiquitinated proteins and the SCF E3 ubiquitin ligase complex in mammalian cells utilizing immunofluorescence and immunoprecipitation analyses. In vitro ubiquitination assay will be used to determine the capacity of these bacterial F-box effectors to recruit and ubiquitinate target proteins utilizing host ubiquitin ligases. Tandem tag affinity purification and proteomics analysis of ubiquitinated proteins targeted for modification by the F- box effectors would identify potential host regulatory elements that are targeted by Legionella during infection. This study will use the clinical isolate strain Lp1 to create deletion mutant lacking the F-box effectors and investigate the contribution of these proteins to the capacity of Legionella to infect and replicate in host cells. The ability of these mutant strains to ubiquitinate target proteins identified by the proteomics screen will be assessed utilizing a cellular model of infection. This work will elucidate the molecular mechanism enabling the human pathogen Legionella pneumophila to subvert host cellular processes by taking control of the host ubiquitination machinery, potentially identifying common features of subversion utilized by other pathogens capable of exerting similar control, which can be targeted by pharmaceuticals to control or prevent infection.
描述(由申请人提供):为了违反人类免疫防御,细胞内细菌可以进入,隐藏和复制在宿主免疫细胞中,并颠覆其免疫功能。这项工作将表征负责这种现象的分子机制,这可能导致新型抗微生物药物靶标的发展。细胞内人病原体肺炎肺癌是严重的细菌性肺炎的病因,称为军团症氏病。吸入雾化细菌会导致疾病爆发,这对于抑制免疫功能的人可能致命。 Legionella利用注入宿主细胞中注入的蛋白质的武器库来控制各种宿主过程并建立细胞内复制生态位。这项研究的目的是阐明肺炎军团蛋白质家族的功能,这些功能被预测通过颠覆宿主的泛素化调节网络来改变宿主细胞反应。这些效应蛋白包含真核F-box结构域,该结构域靶向蛋白质用于泛素化。初步数据表明,在感染过程中,这些F-box效应子被转移到宿主细胞的细胞质中,并与泛素化蛋白相关。最初,这项研究的目的是绘制使用免疫荧光和免疫沉淀分析的哺乳动物细胞中控制F-box效应子与泛素化蛋白相互作用的分子决定因素和SCF E3泛素连接酶复合物。体外泛素化测定法将用于确定这些细菌F-box效应子使用宿主泛素连接酶募集和泛素化靶蛋白的能力。串联标签亲和力纯化和蛋白质组学分析对F-盒效应器进行修饰的泛素化蛋白质的蛋白质组学分析将识别出感染过程中军团菌针对的潜在宿主调节元件。这项研究将使用临床分离株LP1来创建缺乏F-box效应子的缺失突变体,并研究这些蛋白质对军团菌在宿主细胞中感染和复制的能力的贡献。这些突变菌株通过蛋白质组学筛查确定的泛素化靶蛋白的能力将通过感染的细胞模型来评估。这项工作将阐明分子机制,使人类病原体肺炎肺癌通过控制宿主的泛素化机制来颠覆宿主的细胞过程,从而有可能识别其他能够施加相似控制的病原体所利用的颠覆性特征,可以由药物控制或预防感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stanimir Stefanov Ivanov其他文献
Stanimir Stefanov Ivanov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stanimir Stefanov Ivanov', 18)}}的其他基金
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
中央真核代谢检查点激酶雷帕霉素 (MTOR) 调节嗜肺军团菌发病机制
- 批准号:
10092094 - 财政年份:2019
- 资助金额:
$ 5.01万 - 项目类别:
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
中央真核代谢检查点激酶雷帕霉素 (MTOR) 调节嗜肺军团菌发病机制
- 批准号:
10553242 - 财政年份:2019
- 资助金额:
$ 5.01万 - 项目类别:
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
中央真核代谢检查点激酶雷帕霉素 (MTOR) 调节嗜肺军团菌发病机制
- 批准号:
10329977 - 财政年份:2019
- 资助金额:
$ 5.01万 - 项目类别:
Analysis of F-box domain containing effector proteins from Legionella pneumophila
含 F-box 结构域的嗜肺军团菌效应蛋白分析
- 批准号:
7333882 - 财政年份:2008
- 资助金额:
$ 5.01万 - 项目类别:
相似国自然基金
基于亲和导向-邻近反应的复杂体系天然蛋白固定新方法及色谱评价
- 批准号:22374116
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于亲和色谱策略筛选和挖掘磷酸酶PP2A新型调节剂
- 批准号:22377149
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于仿生亲和色谱-质谱策略的肺结核患者血清抗体谱研究
- 批准号:82160027
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于亲和色谱靶点“钩钓”策略研究补肾活血方抗AGEs诱导神经损伤的作用机制
- 批准号:82104621
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
固定化单构象态受体亲和色谱的建立及止喘灵方平喘功效物质研究
- 批准号:82174088
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
相似海外基金
Novel, Targeted Method for Bacteriophage Purification
噬菌体纯化的新型靶向方法
- 批准号:
10698983 - 财政年份:2023
- 资助金额:
$ 5.01万 - 项目类别:
SAMPLE PREPARATION; The Achilles Heel of Mass Spectrometry Based Diagnostics
样品制备;
- 批准号:
8979165 - 财政年份:2016
- 资助金额:
$ 5.01万 - 项目类别:
Cytoskeletal functions in cell aging and disease
细胞衰老和疾病中的细胞骨架功能
- 批准号:
10400494 - 财政年份:2016
- 资助金额:
$ 5.01万 - 项目类别:
Transdermal H2S Sensing Device for Monitoring Peripheral Artery Disease
用于监测外周动脉疾病的透皮 H2S 传感装置
- 批准号:
8643372 - 财政年份:2014
- 资助金额:
$ 5.01万 - 项目类别: